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emergence of a non-sporulating 
secondary phenotype in Clostridium 
(Clostridioides) difficile ribotype 078 
isolated from humans and animals
M. c. connor1, J. W. McGrath1, G. McMullan1, n. Marks1, M. Guelbenzu2,3 & D. J. fairley4
Clostridium (Clostridioides) difficile is a Gram positive, spore forming anaerobic bacterium that is a 
leading cause of antibiotic associated diarrhoea in the developed world. C. difficile is a genetically 
diverse species that can be divided into 8 phylogenetically distinct clades with clade 5 found to be 
genetically distant from all others. Isolates with the PCR ribotype 078 belong to clade 5, and are 
often associated with C. difficile infection in both humans and animals. colonisation of animals and 
humans by ribotype 078 raises questions about possible zoonotic transmission, and also the diversity 
of reservoirs for ribotype 078 strains within the environment. One of the key factors which enables C. 
difficile to be a successful, highly transmissible pathogen is its ability to produce oxygen resistant spores 
capable of surviving harsh conditions. Here we describe the existence of a non-sporulating variant of 
C. difficile ribotype 078 harbouring mutations leading to premature stop codons within the master 
regulator, Spo0A. As sporulation is imperative to the successful transmission of C. difficile this study was 
undertaken to investigate phenotypic characteristics of this asporogenous phenotype with regards to 
growth rate, antibiotic susceptibility, toxin production and biofilm formation.
Clostridium (Clostridioides) difficile is a Gram positive, spore forming anaerobic bacterium that is a leading cause 
of gastroenteritis-associated deaths and currently the most common cause of hospital acquired infection in many 
developed countries1,2. It is also a significant animal pathogen and has been identified as a cause of fatal diarrhoea 
and enteric disease in neonatal piglets3,4. C. difficile is a genetically diverse species that can be divided into 8 phy-
logenetically distinct clades: 1 to 5 and C-I to C-III5,6. Clades 1–5 contain toxigenic ribotypes capable of causing 
human disease5,7, whereas clades C-I and C-II consist only of non-toxigenic strains along with clade C-III, which 
is made up of mostly non-toxigenic isolates with only one toxigenic isolate recently recorded6.
C. difficile clade 5 is genetically distant from all other C. difficile clades, and believed to have diverged from 
clades 1–4 over a period of approximately 85 million years8. Significant variation has been noted within the 
Pathogenicity Locus (PaLoc) of clade 5 itself, whereby two lineages within the clade appear to have acquired their 
PaLoc genes independently7. Isolates with PCR ribotype 078 (R078) belong to clade 5, and are often associated 
with C. difficile in both humans and animals9–12. Notably, R078 is one of the most common ribotypes found 
causing human infection in Northern Ireland13. Prevalence of R078 in both animals and humans raises questions 
about colonisation of both hosts by this ribotype as a possible zoonosis, about modes and routes of transmission, 
and about reservoirs of R078 strains.
One of the key traits which enables C. difficile to be a successful pathogen is its ability to produce robust spores, 
capable of surviving harsh conditions and allowing the oxygen sensitive bacteria to remain viable outside the 
host14. It is known that spore-forming pathogens are highly transmissible15. It has emerged that 15–35% of cases 
of C. difficile infection (CDI) are recurring, which is partially due to these robust spores remaining viable within 
the gut post antibiotic treatment16–18. The mechanism of sporulation is similar in both Clostridiales and Bacillales, 
with the same key components involved; the sporulation regulator, Spo0A, and the sporulation-specific sigma 
factors sigA (σA), sigH (σH), sigF (σF), sigE (σE), sigG (σG), and sigK (σK)15,19. Decisions on the formation of either 
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spores or biofilms relies mainly on the intracellular concentration of phosphorylated Spo0A, with high levels 
leading to spore formation and intermediate levels inducing biofilm formation (38). It is as yet unclear exactly 
what triggers sporulation in C. difficile. Environmental conditions such as nutrient starvation, pH and oxygen 
exposure may have a role to play20, whilst other mechanisms such as quorum sensing could also be involved21.
Although sporulation is imperative to transmission of oxygen sensitive bacteria, non-sporulating variants 
have been observed in normally sporulating bacterial species. Bacillus anthracis for example has been found to 
produce a non-sporulating variant in vitro, due to nutrient abundance reducing the selective pressure to produce 
spores22. Here we describe the existence of a non-sporulating population of C. difficile R078. We show that after 7 
days anaerobic incubation at 37 °C R078 isolates appeared to produce a secondary colony phenotype. These sec-
ondary colonies have a smooth, grey appearance, with a much larger, spreading colony morphology whilst micro-
scopic examination suggested this secondary phenotype may be non-sporulating. As sporulation is imperative to 
the successful host-to-host transmission of C. difficile this study was undertaken to investigate counter-intuitive 
observation.
Results
emergence of secondary phenotype. R078 isolates produced a morphologically different, secondary 
colony variant after incubation for 7 days on fastidious anaerobe agar with horse blood (FAABL). Colonies of the 
wild-type phenotype (As; Hs) were observed after 48 h growth on FAABL under anaerobic conditions (Fig. 1). 
Further investigation of these colonies using microscopy showed the presence of spores as well as vegetative cells 
(Fig. 2A). In contrast, the secondary colony variants (Ans; Hns), which emerged after 7 days anaerobic incubation 
at 37 °C on FAABL (Fig. 1), showed the presence of vegetative cells only (Fig. 2B). Both phenotypes display a 
distinct colony morphology, with the (initial) sporulating phenotype giving rise to a small, rough, white col-
ony and the non-sporulating variant a much larger, smooth, grey colony (Fig. 1B). The non-sporulating variant 
Figure 1. (A) Non sporulating variant of C. difficile 078 emerging from the wild type culture after 7 days 
incubation at 37 °C under anaerobic conditions on FAABL. (B) Both colony variants can be sub-cultured 
independently after initial separation (24 h incubation at 37 °C under anaerobic conditions on FAABL). Wild 
type cells give rise a small, rough, white colony type whist the non-sporulating variants produce much larger, 
smooth, grey colonies.
Figure 2. (A) Spore-stain image of Hs isolate at x 1000 magnification. (B) Spore-stain image of Hns (non-
sporulating) secondary phenotype at x 1000 magnification. Spores are identified by observation of green 
staining, while vegetative cells are red/pink.
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appears to arise as sub-populations or micro colonies within the sporulating colonies and can be sub-cultured 
independently. No reversion to a sporulating phenotype was observed after at least five serial subcultures of the 
non-sporulating variants. Of ten R078 isolates tested for the appearance of the secondary phenotype, all ten iso-
lates showed the emergence of the secondary phenotype. To further investigate the secondary R078 phenotype, 
one human R078 isolate and one animal R078 isolate were selected for further detailed study.
Multi-locus variable number tandem repeat analysis. To rule out the possibility that the secondary 
phenotype was due to contamination or a mixed culture, MLVA was performed on each isolate obtained. MLVA 
confirmed the R078 strains used were distinct from each other, however, the phenotypic variants could not be dis-
tinguished using MLVA. The sporulating (As; Hs) and non-sporulating phenotypes (Ans; Hns) gave identical MLVA 
profiles for both pairs of human and animal isolates (Table 1). This is the expected result if the non-sporulating 
isolates were mutants derived from the same parental strains in each case.
Assessing sporulation in As, Ans, Hs and Hns. Alcohol shock survival was used to investigate sporulation 
within the parental strains and proposed non-sporulating variants. Relative to water-only (no alcohol) controls, 
alcohol shock significantly reduced the number of CFU recovered for all isolates; As (p < 0.01) and Ans (p < 0.001) 
and Hs (p < 0.01) and Hns (p < 0.001). An average of 37.5% ± 0.5% CFU were recovered from As and Hs after alco-
hol shock (Fig. 3[i,iii]), indicating the presence of spores within the parental strains. Viable counts from sporulat-
ing variants after alcohol shock were dramatically reduced compared to controls due to killing of vegetative cells 
in the cultures (Fig. 3[i,iii]). After alcohol shock of the Ans and Hns variants, viable counts were zero, indicating 
complete absence of spores (Fig. 3[ii,iv]).
Growth rate analysis of As, Ans, Hs and Hns. The growth rate of each phenotype was investigated 
(Fig. 4) with no significant difference noted between As and Ans (p > 0.05) and Hs and Hns (p > 0.05). Growth 
rates obtained for each isolate were as follows; As: 0.24 ± 0.02 h−1, Ans: 0.28 ± 0.04 h−1, Hs: 0.20 ± 0.02 h−1, Hns: 
0.25 ± 0.02 h−1. The sporulating isolates gave higher optical density readings, likely due to the presences of spores.
Crystal violet biofilm assay. To assess if any significant difference in biofilm production was associated 
with loss of the sporulation phenotype a Crystal Violet assay was employed23, to allow for the quantification of 
biofilm production by As and Ans, and Hs and Hns. If linked, a sub-population displaying increased biofilm for-
mation could confer a plausible population-level advantage on strains exhibiting a non-sporulating behaviour. 
However, although variation was observed in biofilm production, it was not sufficient to conclude a significant 
difference in biofilm production (Fig. 5).
Toxin production in As, Ans, Hs and Hns. The ability of each isolate (As, Ans, Hs and Hns) to produce toxin 
was assessed to determine any difference in toxigenicity between the variants. Whilst all isolates produced toxin, 
with a maximum level measured at 14.5 h (indicating the beginning of stationary phase); sporulating isolates (As; 
Hs) produced significantly more toxin than the non-sporulating isolates (Ans; Hns) (p < 0.001). Although the non 
sporulating variants produced less toxin, toxin production was still observed, suggesting the non sporulating 
variants are still toxigenic (Fig. 6). No significant difference in maximum toxin production was noted between Ans 
and Hns (p > 0.05). However, Hs produced significantly more toxin than As (p < 0.001).
Motility assay. R078 is typically described as non-motile24 however motility was assessed to document if 
the secondary phenotype displayed any motility. Flocculent growth was observed from both phenotypes for both 
human and animal isolates in BHI (0.175%) agar (Fig. 7). This growth pattern indicates a non-motile organism 
as previously reported for R07824.
Antimicrobial susceptibility to vancomycin and metronidazole. The susceptibility of each pheno-
typic variant to vancomycin and metronidazole was investigated as they are the primary antibiotics employed to 
treat CDI25. No significant difference was noted between As and Ans, and Hs and Hns, indicating each phenotype 
displayed similar susceptibility to both metronidazole and vancomycin. Overall, each isolate displayed more sus-
ceptibility to metronidazole than vancomycin, giving a larger zone of inhibition (p < 0.05) (Fig. 8).
Susceptibility to metronidazole was further assessed using MIC test strips. These confirmed the animal iso-
lates were more susceptible to metronidazole with MIC of 0.5 μg compared to the human isolates with MIC of 
0.75 μg. No difference in susceptibility to metronidazole between the sporulating and non-sporulating pheno-
types was observed for either the human or animal derived isolates (p > 0.05).
MLVA profile
Isolate A6a B7 C6 E7 F3 G8 H9
As — 21 31 5 5 10 2
Ans — 21 31 5 5 10 2
Hs — 17 9 9 5 7 2
Hns — 17 9 9 5 7 2
Table 1. MLVA profiles of animal and human isolates; As, Ans, Hs and Hns. aThe A6 allele is consistently absent 
from R078 isolates (39).
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Illumina whole genome sequencing and analysis of spo0A. Purified DNA extracts of As, Ans, Hs 
and Hns were subject to Illumina sequencing, along with reference R078 isolate, M120. The aim was to assess any 
genetic differences between the isolates which may explain the emergence of the non-sporulating secondary phe-
notype. The sequencing statistics for each isolate showed a low number of contigs for a large genome, indicating 
good coverage and reasonably complete draft genomes (Supplementary Table S1).
Figure 3. Recovery of spores after alcohol shock with 70% (v/v) ethanol for 1 h at room temperature compared to 
the control, CFU obtained without alcohol shock, (C). (i) As isolate, (ii) Ans isolate, (iii) Hs isolate, (iv) Hns isolate.
Figure 4. Growth of As, Ans, Hs and Hns in BHI over 24 h at 37 °C under anaerobic conditions. A) As (o) and Ans 
(●), B) Hs ( ) and Hns (■).
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To investigate the sporulation differences seen between the sporulating and non-sporulating R078 variants, 
spo0A sequences were extracted from each assembly and for the sporulating M120 reference genome, using the 
SEED viewer interface. The entire spo0A gene was found to be present in each assembly. However, mutations that 
introduce stop codons into both the animal (Ans) and human (Hns) variants were found (Fig. 9).
A non-synonymous mutation was present in the Ans spo0A gene, at the 7th codon converting a glutamic acid 
codon (GAA) into a stop codon (TAA) (Fig. 9). Two mutations were identified in the Hns spo0A gene, both 
also introducing stop codons. The first of these occurred at the 162nd codon, again converting a glutamic acid 
codon (GAA) to TAA and the second at the 227th, also introducing a TAA stop codon. In both non-sporulating 
strains these mutations would be expected to result in truncated gene products (Fig. 9). These were the only 
non-synonymous mutations found within the assemblies, this is consistent with the MLVA analysis confirming 
the non-sporulating strains were mutants derived from the sporulating parental strain in each case. Within each 
assembly, the spo0A genes lay within large contigs with good (over 30X) coverage. This strongly suggests that the 
mutations observed do not appear to be sequencing errors: Sanger sequencing of the whole gene in each strain 
was also completed. No mutations were seen in the sporulating isolates, As and Hs, which in turn were identical 
to the M120 reference strain (Fig. 9).
Within the spo0A gene of Ans, a stop codon in the N-Spo0A at the 7th amino acid would be expected to termi-
nate translation after expression of a short peptide with the sequence MGGFLV (Fig. 9). Within the spo0A gene of 
Hns, the stop codon at the 162nd amino acid would allow expression of the entire N-domain, according to a study 
by Lewis et al.26. However, the C-domain would be absent (Fig. 9). This domain is the transactivation domain and 
is responsible for DNA binding and transcription activation. This would potentially prevent phosphorylation of 
Spo0A and affect transcription of several hundred genes, including sporulation27.
Discussion
This study demonstrated that an asporogenous C. difficile phenotype emerges after prolonged incubation of some 
R078 strains on FAABL, in vitro. As well as conventional single colony subculture, MLVA analysis confirmed the 
observed phenotypic differences were not due to separation of distinct strains from mixed cultures (Table 1). 
Further study of the variants derived from one human and one animal R078 strain found no differences in growth 
rate, motility or vancomycin/metronidazole susceptibility relative to the original “wild type” strain. Illumina 
sequencing allowed for genetic comparison of the different phenotypes. The spo0A gene in both non-sporulating 
Figure 5. Biofilm formation of each isolate measured via Crystal Violet assay23. Cultures were grown statically 
for 6 days in BHI under anaerobic conditions at 37 °C.
Figure 6. Maximum toxin production of each phenotype for animal and human isolates. Isolates were grown in 
BHI media under anaerobic conditions at 37 °C. Sampling began at 14.5 h after inoculation with samples taken 
every 3 h thereafter, for a total of 24 h: Maximum toxin production was observed at 14.5 h.
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variants were found to harbour premature stop codons (Fig. 9), most likely resulting in truncation of the pre-
dicted gene product (Fig. 9).
As previously mentioned, non-sporulating variants have been observed in other species. For example, Bacillus 
anthracis, and other Bacillus spp., have been found to produce a non-sporulating variant in vitro, where nutri-
ents are abundant and therefore the selective pressure to produce spores is low22,28–30. Colonies produced by 
the asporogenous variant of B. anthracis are translucent and larger than their sporulating counter parts, as seen 
with the non-sporulating C. difficile isolates in this study (Fig. 1). Furthermore, various mutations were also 
seen occurring at different points within the spo0A gene of the non-sporulating B. anthracis variants22. The 
Figure 7. Motility of each isolate in BHI 0.175% agar for 24 h at 37 °C under anaerobic conditions. (A) Animal 
isolates: As and Ans, (B) Human isolates: Hs and Hns.
Figure 8. Susceptibility to metronidazole and vancomycin measured through zone of inhibition (mm). Isolates 
were grown anaerobically at 37 °C on FAABL for 24 h in the presence of antimicrobial discs containing 5 μg of 
(A) Metronidazole, (B) Vancomycin.
7Scientific RepoRtS |         (2019) 9:13722  | https://doi.org/10.1038/s41598-019-50285-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
emergence of this non-sporulating phenotype in B. anthracis appears to be solely due to conditions which do 
not promote stress induced sporulation – for example nutrient depletion, which has been determined as the key 
factor inducing sporulation in B. anthracis22,31. Abundance of nutrients could also explain the emergence of the 
non-sporulating R078 variant in this study as the R078 isolates were only grown on FAABL which is a nutrient 
rich medium. However, it is as yet unclear what exactly triggers sporulation in C. difficile. Environmental condi-
tions such as nutrient starvation, pH and oxygen exposure may have a role to play20. With B. anthracis, reversion 
to the sporulating phenotype has not been completed through stress induced mechanisms, however sporulation 
has been restored in the asporogenous isolates through phage transduction32.
The non-sporulating mutants isolated in this study produced significantly less toxin than their sporulating 
counterparts (Fig. 6). The master regulator associated with sporulation is the Spo0A regulon, which has not only 
been found to regulate sporulation, but also motility, biofilm formation and many metabolic pathways such as 
glucose fermentation17,20,23,33. Mutations in the spo0A gene have previously been found to have an adverse effect 
on toxin production within C. difficile34. Mackin et al. found this effect on toxin production to be strain specific, 
as the molecular mechanisms for expression of the C. difficile toxin genes differ across phylogenetically distinct 
strains35. Inactivation of Spo0A has been seen to negatively affect toxin gene expression in some ribotype 027 
isolates35.
However, in contrast to the results observed in this study, Mackin et al. reported that spo0A inactivation in the 
R078 isolate used in their study produced similar amounts of toxin when compared to the sporulating counter 
parts35. In this study those isolates with a mutation in the spo0A gene produced significantly less toxin than their 
sporulating counterparts (Fig. 6).
The results observed in this study are similar to that seen by Underwood et al., who reported toxin production 
was approximately 10% less in C. difficile 630 spo0A knock out isolates compared to the wild type C. difficile 630 
isolate34. Variation in toxin production has been noted across different ribotypes, with increased toxin produc-
tion linked to increased virulence and disease. Ribotype 027 has been shown to display increased levels of toxin 
production36 in comparison to other ribotypes such as R106, R001 and R012. However these isolates displaying 
‘decreased’ levels of toxin production still have the ability to cause serious disease36 so the relationship between 
quantity of toxin produced and virulence is not straightforward. Studies in mice have found that spo0A mutant 
derivatives still caused intestinal disease however they lack the ability to persist outside the host, ultimately pre-
venting transmission15. Therefore sporulation has been highlighted as a key factor in transmission of C. difficile 
and recurrence of CDI15.
Figure 9. Alignment of sequences of spo0A for each isolate. M120 – reference 078, As- animal isolate phenotype 
1, Ans - animal isolate phenotype 2 (with stop codon at the 7th codon- x), Hs - human isolate phenotype 1, Hns 
- human isolate phenotype 2 with stop codon at the 162nd codon - x).
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In this study, the lack of sporulation did not affect motility or biofilm formation (Fig. 5; Fig. 7). Motility and 
biofilm formation are important characteristics of many bacterial species for both the colonisation and evasion of 
hostile environments37, their roles in C. difficile infection have been widely studied. Motility is not a characteristic 
shared by all C. difficile strains with Baban et al. reporting C. difficile isolates displaying varying degrees of motil-
ity24. C. difficile R20291 (epidemic R027) and C. difficile 630 (R012) are motile, however members of the R078 are 
known to be non-motile24. Biofilm formation and sporulation have been found to be linked in other bacteria15,23. 
This relationship has been studied extensively in Bacillus subtilis where it has been shown that biofilm formation 
is regulated by Spo0A38: Absence of a functional spo0A gene may result in lack of biofilm formation17. Though it 
was hypothesised that the mutation identified in spo0A of the non sporulating isolates would also affect biofilm 
formation, this was not the case. No significant difference in biofilm formation was detected between the sporu-
lating and non sporulating isolates (Fig. 5).
Toxin production is a key factor contributing to the disease caused by C. difficile, however infection requires 
successful colonisation of the gut. The processes of adherence, colonisation and sporulation therefore play a 
particularly important role in infection. Furthermore, a number of spore proteins have been identified as 
pro-inflammatory immunogenic agents, suggesting they may also contribute to the pathogenesis associated with 
CDI39–41. Further research into the mechanism which allows successful C. difficile colonisation of the host is 
important, particularly due to the increase in recurrent infections being reported in 15–35% of cases of CDI16,17.
This study does not suggest a regulatory effect where the non sporulating population has ‘switched off ’ spor-
ulation. The ability to sporulate in these variants appears to be lost, rendering the vegetative cells vulnerable to 
aerobic conditions, thereby preventing transmission. In biological terms the emergence of non-sporulating phe-
notypes is counter-intuitive for a strict anaerobe such as C. difficile that relies on transmission via spores. Previous 
studies have investigated increased sporulation as a factor that increases virulence42. This study focused on only 
four isolates from R078, further investigation into other R078 isolates, along with other ribotypes would be just. 
The emergence of this non sporulating variant may be due to phenotypic heterogeneity, where potential benefits 
arise through the ‘division of labour’43. This phenomenon suggests that individual cells within a colony can dis-
play different phenotypic traits which may lead to interactions benefiting the colony over all43. Whether a selective 
advantage acting at a population level could explain the emergence of non-sporulating C. difficile phenotypes is 
unclear. The robust spores produced by C. difficile are what allows this pathogen to survive and persist in such a 
wide range of environments44,45. No obvious advantage in producing the asporogenous phenotype has yet been 
identified however. Further investigations are needed to determine if non-sporulating populations arises in vivo, 
and what role this may play in C. difficile infection and host colonisation.
Materials and Methods
isolation of phenotypic variants. Human C. difficile R078 isolates were obtained from archives at the 
Kelvin Laboratories, Royal Victoria Hospital, Belfast. Animal C. difficile R078 isolates were cultured from animal 
samples supplied by the Veterinary Science Division (VSD), Agri-Food Biosciences Institute (AFBI), Belfast. 
Human (n = 5) and animal (n = 5). Each isolate was subject to at least two single-colony sub-cultures, to confirm 
these cultures were axenic. R078 isolates were grown on fastidious anaerobe agar with horse blood (FAABL; 
Oxoid, Basingstoke, UK) for seven days under anaerobic conditions (N2/CO2/H2) at 37 °C. Two distinct colony 
morphologies were observed with all ten R078 isolates tested. These could be separated and sub-cultured inde-
pendently on FAABL. One human isolate and one animal isolate were selected for further investigation. Isolates 
were categorised based on their observed sporulation patterns as follows: animal sporulating phenotype (As), 
animal non-sporulating phenotype (Ans), human sporulating phenotype (Hs) and human non-sporulating phe-
notype (Hns). Cells/spores, from each colony morphology were harvested from FAABL and suspended in 20 μl 
sterile phosphate-buffered saline (PBS), smeared uniformly over a microscope slide and heat fixed. The cells/
spores were then subject to staining for 10 min, in the presence of malachite green solution (0.5% [w/v]: Sigma 
Aldrich, Irvine, UK), according to method of Schaeffer and Fulton46. The slides were washed with dH2O and 
counter stained with Safranin (2.5% [w/v]: Sigma Aldrich, Irvine, UK) for 30 s. The slides were washed, air dried 
and viewed using oil emersion at x 1000 on a Leica DMR microscope (Leica Microsystems Inc., Milton Keynes, 
UK). Spores were identified by observation of green staining, while vegetative cells are red/pink.
Multi-locus variable number tandem repeat analysis (mlva). To further confirm cultures were 
axenic, and that separate colony types were not due to the co-occurrence of two otherwise similar strains, MLVA 
was used to analyse As, Ans, Hs and Hns isolates. The MLVA method described by Fawley et al.47 was employed. In 
brief, each repeat locus was amplified in a singleplex PCR, with a final volume of 10 μl. Each reaction contained; 
1x Promega Flexi PCR Buffer (Promega, Southampton, UK), Nuclease Free Water (Sigma Aldrich, Irvine, UK), 
Bovine Serum Albumin (0.2 mg/ml) (Sigma Aldrich, Irvine, UK), MgCl2 (3 mM) (Promega, Southampton, UK), 
forward primer (0.05 µM) and reverse primer (0.05 µM) (Integrated DNA Technologies, Leuven, Belgium). PCR 
primers are shown in Table 2.
Thermal cycling conditions were as follows: 95 °C for 10 min, followed by 34 cycles of 95 °C for 30 s, 51 °C for 
30 s and 72 °C for 30 s, followed by 72 °C for 5 min.
Post amplification, PCR products were diluted (1:10) with nuclease free water (NFW) (Sigma Aldrich, Irvine, 
UK). 1 μl of diluted PCR product was added to 9 μl Hi-Di formamide containing GeneScan 600 LIZ Size Standard 
(Applied Biosystems, Warrington, UK). Diluted samples were separated using capillary electrophoresis on a 
3730XL Genetic Analyzer using POP-7 polymer and a 36 cm capillary array (Applied Biosystems, CA, USA). 
Fragment size data were analysed using GeneMarker software (SoftGenetics, LLC, USA) to assign MLVA profiles.
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Assessing sporulation in R078 colony variants. C. difficile R078 isolates designated as As, Ans, Hs and 
Hns were sub-cultured on FAABL under anaerobic conditions at 37 °C for 72 h. Colonies were harvested and cells 
immediately subjected to alcohol shock in 70% (v/v) ethanol for 1 h at room temperature48 to kill vegetative cells. 
Subsequently a 10-fold serial dilution (undiluted to 10−3) was carried out in sterile PBS (Sigma Aldrich, Irvine, 
UK) for each isolate. Aliquots of each dilution (100 μl) were plated onto Brazier’s agar (Oxoid, Basingstoke, UK) 
in triplicate, and incubated anaerobically at 37 °C for 48 h. A control experiment was carried out (working in 
the anaerobic chamber) where the cells were suspended in pre-reduced sterile distilled H2O for 1 h, as opposed 
to 70% [v/v] ethanol. An identical 10-fold serial dilution was carried out before plating onto Brazier’s agar, in 
triplicate. Visible colonies were enumerated after incubation to estimate Total Viable Counts (TVC) for each 
condition49.
Growth rate analysis. Brain Heart Infusion broth (BHI) (Oxoid, Basingstoke, UK) was inoculated with 
a single colony of As, Ans, Hs and Hns and grown anaerobically for 24 h to an OD600 of 1.0, measured using an 
Eppendorf Biophotometer (Eppendorf, Stevenage, UK). Growth assays were carried out on technical replicate 
cultures (n = 12), grown in 96-well microtitre plates. BHI broth (180 μl per well) was aliquoted into sterile plates 
and pre-reduced in an anaerobic cabinet for 5 h prior to inoculation with 20 μl of a log phase broth cultures of 
each isolate. Uninoculated BHI-only controls (n = 12) were included in each plate. Plates were sealed in the anaer-
obic chamber and incubated at 37 °C using a FLUOstar Omega Microplate reader (BMG Labtech, Aylesbury, UK). 
Readings were taken every hour, with shaking for 20 s prior to OD600 measurements, for 24 h.
Crystal Violet biofilm assay. As, Ans, Hs and Hns isolates were grown anaerobically on FAABL agar for 
72 h. 5 ml BHI was pre-reduced for 5 h prior to inoculation with a single colony of each phenotype. Cultures were 
incubated anaerobically for 24 h at 37 °C.
Biofilm assays were carried out according to the method of Dawson et al.23. In brief, after 24 h growth, 20 μl of 
each strain was inoculated into 180 μl of pre-reduced BHI broth (1/10 dilution) with replication (n = 12) in micr-
otitre plates. BHI-only controls were included for every well containing C. difficile (n = 12). Plates were sealed in 
the anaerobic chamber and incubated without shaking at 37 °C, for six days.
After incubation, media was aspirated and each well washed once with sterile PBS. 200 μl of 1% (v/v) Crystal 
Violet (Sigma Aldrich, UK) was added to each well and plates were incubated for 30 min at room temperature. 
After staining, wells were washed three times with sterile PBS. 200 μl of methanol (Sigma Aldrich, Irvine, UK) was 
added to each well to solubilise the remaining Crystal Violet, which will be representative of biofilm formation. 
After incubation at room temperature for 15 min, OD595 measurements were taken using a FLUOstar Omega 
Microplate reader (BMG Labtech, Aylesbury, UK).
toxin production. In order to confirm the ability to produce toxin was not affected by loss of sporulation, 
As, Ans, Hs and Hns isolates were grown anaerobically at 37 °C on FAABL for 72 h. 5 ml BHI broth was pre-reduced 
for 5 h prior to inoculation with a single colony of each isolate. Cultures were incubated anaerobically at 37 °C. 
Sampling began 14.5 h after inoculation, with samples taken every 3 h thereafter, for a total of 24 h, in triplicate. 
Presence of toxin in the cultures was evaluated at each time point using the Premier Toxins A&B kit (Meridian 
Bioscience, London, UK) in accordance with the manufacturer’s instructions, where optical density can be used 
to determine level of toxin present.
This assay is used to detect the toxins produced by toxigenic C. difficile, toxins A and B, using toxin specific 
antibodies. As per manufacturers instruction, 50 µl of broth culture was added to the antibody coated well fol-
lowed by horseradish peroxidase (HRP)-conjugated anti-toxin A and B antibodies are added to wells. The pres-
ence of either toxin is detected the HRP-conjugated antibodies will bind to the toxins, which will remain in wells 
after washing. A chromagen is then added to the wells which will bind to HRP-conjugated anti-toxin and a blue 
colour will form. After 10 min, the reaction is stopped using 1 M Phosphoric acid. This colour intensity can be 
Primer ID Sequence 5′–3′ Repeat motif Location
A6_F FAM-TTAATTGAGGGAGAATGTTAAA AAGAGC 755721
A6_R AAATACTTTTCCCACTTTCATAA
B7_F ATTO550-CTTAATACTAAACTAACTCTAACCAGTAA ATCTTCT 3688632
B7_R TTATATTTTATGGGCATGTTAAA
C6_F FAM-GTTTAGAATCTACAGCATTATTTGA TATTGC 3239736
C6_R ATTGGAATTGAATGTAACAAAA
E7_F ATTO550-TGGAGCTATGGAAATTGATAA ATAGATT 167124
E7_R CAAATACATCTTGCATTAATTCTT
F3_F ATTO565-TTTTTGAAACTGAACCAACATA TTA 1954915
F3_R ACAAAAGACTGTGCAAATATACTAA
G8_F ATTO565-TGTATGAAGCAAGCTTTTTATT TAAAAGAG 664660
G8_R ACCAAAAATTTCTAACCCAAC
H9_F HEX-GTTTTGAGGAAACAAACCTATC TCTTCTTCC 4116072
H9_R GATGAGGAAATAGAAGAGTTCAA
Table 2. MLVA primers according to Fawley et al.47.
1 0Scientific RepoRtS |         (2019) 9:13722  | https://doi.org/10.1038/s41598-019-50285-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
quantified using using a BMG FLUOstar Optima Fluorescence spectrophotometer (BMG Labtech Ltd, Aylesbury, 
UK) at OD 600 nm allowing for a positive or negative results to be recorded. Positive toxin production was indi-
cated at OD600 ≥ 0.150.
Motility assay. Motility was assessed using the qualitative assay of Stabler et al.50 with modification. As, Ans, 
Hs and Hns isolates were grown anaerobically on FAABL for 48 h. Working in the anaerobic chamber, triplicate 
colonies of each isolate were removed and resuspended in 50 µl sterile PBS (Sigma Aldrich, Irvine, UK) and a 
ten-fold serial dilution (undiluted to 10−4) was carried out. 10 ml of pre-reduced BHI containing 0.175% (w/v) 
agar was inoculated with each dilution, by carefully dropping 10 µl onto the surface, with minimum disturbance 
of the medium. Broths were incubated without shaking for 24 h under anaerobic conditions before being removed 
and photographed.
Antibiotic susceptibility assay. As, Ans, Hs and Hns isolates were grown anaerobically at 37 °C on FAABL 
for 24 h. Cells were harvested and re-suspended in sterile PBS to an OD600 of 0.6. 200 μl of cell suspension was 
spread evenly onto FAABL (n = 3) and antibiotic test discs of metronidazole (5 μg) and vancomycin (5 μg) (Oxoid, 
Basingstoke, UK) were placed onto each plate. Plates were incubated anaerobically at 37 °C for 24 h. After incuba-
tion the zone of inhibition for each antibiotic was measured.
The Minimum Inhibitory Concentration (MIC) of metronidazole was also estimated using MIC test strips 
(Liofilchem, Teramo, Italy). As, Ans, Hs and Hns isolates were plated onto FAABL as previously described. The MIC 
test strip was placed on the plate and incubated anaerobically at 37 °C for 24 h. MIC was determined by reading 
the concentration of the MIC test strip where the zone of inhibition began, according to the manufacturer’s 
instructions.
Statistical analysis. All statistical analyses were carried out using GraphPad Prism 5. One-Way Analysis 
of Variance (ANOVA) was employed to determine significant differences in sporulation, growth rate, antibi-
otic susceptibility, toxin production and biofilm formation within each of the corresponding sporulating and 
non-sporulating isolates. Statistical significance was determined at p < 0.05.
Illumina whole genome sequencing. As, Ans, Hs and Hns were cultured overnight in BHI broth, along with 
reference isolate, M120. Broth cultures were centrifuged at 20,000 × g for 5 min and the cell pellets resuspended 
in 200 µl of MagNa Pure Bacteria lysis buffer (Roche Diagnostics, UK). DNA was extracted using the DNA/
Viral Kit on the MagNA Pure Compact System (Roche Diagnostics, UK) in accordance with the manufacturer’s 
instructions. The purified DNA was eluted into a final volume of 100 µl, quantified using a Quantus fluorometer 
(Promega, UK) and concentrations normalised to 30 ng/µl. DNA samples were submitted for Illumina sequencing 
to the Microbes NG (University of Birmingham, UK) service. Samples were processed by MicrobesNG as follows: 
sequencing libraries were prepared using the Nextera DNA Sample Preparation Kit (Illumina, USA). Paired-end 
sequencing of the resulting libraries (2 × 250 bp) was carried out on the Illumina MiSeq™ platform (Illumina, 
USA).
Initial bioinformatics analysis was carried out by MicrobesNG. In brief, Kraken, a taxonomic sequence classi-
fication system, was used to identify the closest available reference genome – C. difficile 630. Sequence reads were 
mapped onto the reference genome using BWA-MEM (http://bio-bwa.sourceforge.net). De novo assembly was 
performed using SPades (http://bioinf.spbau.ru/spades) with mapping onto reference genome using BWA-MEM 
to assess quality.
Assemblies were analysed further using the RAST server51 (http://rast.nmpdr.org) to predict open reading 
frames (ORFs), followed by annotation using the SEED database52. Annotated assemblies were examined using 
the SEED Viewer.
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